Balsamo, Gianna B.

HRN: 28-96-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2026
OXACILLIN 500MG (VIAL)
05/16/2026
05/23/2026
IV
45mg
Q12
Neonatal Sepsis ( Staph Epidermidis)
Checking Initial Appropriateness 

 Indication:  Culture-directed    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines